Gate2Brain obtains FDA Orphan Drug Designation for G2B-002

, ,
US FDA grants Orphan Drug Designation for G2B-002 in 2025, underscoring U.S. regulatory support for…

Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain

,
Image: Marina Plaza Press release New research highlights how advanced peptide shuttles—the…

Gate2Brain Receives EMA Orphan Drug Designation for Its Groundbreaking G2B-002

, ,
PRESS RELEASE Barcelona, November 2024 – Gate2Brain, a cutting-edge technology platform focused on…

The UB spin-off Gate2Brain wins the Senén Vilaró Prize for the development of technology that facilitates drug delivery to the brain

, ,
Barcelona, 20 December 2023 The University of Barcelona (UB) spin-off Gate2Brain has been awarded…

Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck

,
Meritxell Teixidó: “Una gran quantitat de fàrmacs no arriben al cervell, i la tecnologia de Gate2Brain…
Els valors de la Universitat La UB reivindica la seva identitatUniversitat de Barcelona

Gate2Brain’s CEO part of the values campaign of the University of Barcelona under the motto “I am Innovative”

Els valors de la Universitat La UB reivindica la seva identitat El transport públic, els mitjans de…
Cuatro proyectos biomédicos innovadores reciben el impulso de la Fundación ”la Caixa” para acelerar su llegada al mercado y a la sociedadFundació La Caixa

Four innovative biomedical projects boosted by the Fundació “la Caixa”

,
Cuatro proyectos biomédicos innovadores reciben el impulso de la Fundación ”la Caixa”…
Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21Foment del Treball

Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21

En el marc de la celebració dels seus 250 anys i de la seva col·laboració amb la Fundació Mobile…
round table at 2021 Worldwide Congress Barcelona & 4YFN

On the occasion of the Mobile World Congress Barcelona & 4YFN, Gate2Brain will participate in the round table session organized by Foment del Treball, on “Innovation & Scalability for the new generations”

Foment intensifica la seva presència al MWC i al 4YFN 2021 La patronal organitza una jornada en un…

Gate2Brain along with other 26 Catalan startups has been granted financial support by Startup Capital d’Acció 2020

La línia Startup Capital d’ACCIÓ 2020, amb un 25% més de pressupost, ha beneficiat 27 empreses,…

BStartup of Banco de Sabadell invests in Gate2Brain biotech

, ,
Su tecnología tiene como objetivo transportar fármacos al cerebro aumentando la eficacia y disminuyendo…
Gate2Brain

Gate2Brain seeks up to 3 million euros to reach the clinical trial

,
La start up, que desarrolla una tecnología para transportar fármacos al cerebro, utilizará los fondos…

The Mind the Gap program of Botín Foundation invests 1.5 million euros in three new biotech startups

, ,
El programa Mind the Gap de la Fundación Botín invierte 1,5 millones de euros en tres nuevas startups…
Gate2Brain

Launch of Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness

Launch of Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness …
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social